Book Value per Share: pacb.com (PACB)

Graphic logo of Pacific Biosciences (PACB)

Pacific Biosciences (PACB) is a leader in high-precision long-read genome sequencing, holding unique patents for SMRT technology used to detect complex mutations. Manufacturing facilities in the US ensure the production of systems indispensable for cutting-edge science. The current indicator is -0.11. The confirmed price history on this chart is based on the implementation of the Revio platform, which is driving demand for consumables.

Pacific Biosciences of California (PACB) Equity per Share: for the period 07/04/2022 - 10/28/2026
Manufactured products of PacBio

Book value per share represents the difference between the company's total assets and liabilities, divided by the number of shares outstanding. The trend in equity per share allows for an assessment of the real value of Pacific Biosciences (PACB) net assets, confirming the financial stability of this high-precision DNA sequencing leader through the capitalization of unique technological patents and the trust of the scientific community.

Competitors of Pacific Biosciences (PACB)

TEM: Book Value per Share|QGEN - Accounting Value per Share|Ionis Pharmaceuticals (IONS) - Book Value per Share|repligen.com (RGEN) - Net Assets per Single Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|sarepta.com - Book Value per Share|Net Assets per Single Share Twist Bioscience, Inc.|TXG - Share Book Value|NTLA: Book Value per Share|Stoke Corp (STOK) - Book Value per Share|Book Value per Share BLFS|Accounting Value per Share wavelifesciences.com|MAZE (Maze Therapeutics) - Book Value per Share|Net Assets per Share Sionna Therapeutics, Inc. (SION)|Prime Medicine Corp (PRME) - Book Value per Share|Share Book Value Taysha Corp TSHA|Book Value per Share QURE (uniQure N.V.)|MGTX - Net Assets per Share|RGNX (REGENXBIO) - Book Value per Share|Accounting Value per Share Solid Biosciences Inc|OCGN - Accounting Value per Share|Accounting Value of a Share Benitec Corp|Book Value per Share Design Therapeutics (DSGN)|Net Assets per Single Share rocketpharma.com (RCKT)|Book Value per Share FDMT|Lexeo Therapeutics Inc. - Net Assets per Share|KRRO (Korro Bio, Inc) - Net Assets per Single Share|EDIT: Net Asset Value per Share|Silence Therapeutics - Net Assets per Single Share|ProQR Therapeutics (PRQR) - Net Assets per Share|Book Value per Share CDXS|Accounting Value per Share Sangamo Therapeutics Inc.|NAUT (Nautilus Biotechnology) - Book Value per Share|Net Assets per Share Metagenomi Therapeutics (MGX)|DTIL: Book Value per Share|Generation Bio Co - Net Asset Value per Share|Boundless Bio (BOLD) - Net Assets per Single Share|XCUR - Equity per Share|IMNN (imunon.com) - Book Value per Share|Phio Pharmaceuticals Corp. (PHIO) - Accounting Value per Share|Book Value per Share MBIO (Mustang Bio Inc)|Net Asset Value per Share RNAZ|BNGO (Bionano Genomics, Inc.) - Net Assets per Single Share|Net Assets per Share APDN (Applied DNA Sciences Inc)|Bluebird Bio (BLUE) - Net Assets per Single Share|Share Book Value ImmunoPrecise Antibodies Ltd IPA|Omega Therapeutics - Book Value per Share|OMIC - Book Value per Share|RGLS (Regulus Therapeutics Inc.) - Book Value per Share|Syros Pharmaceuticals Inc. (SYRS) - Accounting Value per Share|Book Value per Share Codex DNA|Net Assets per Single Share TRACON Pharmaceuticals, Inc|Book Value per Share Unity Biotechnology UBX